FindTrial
Sign In

Study on Perioperative Blood Protection Scheme Based on Total Hip Arthroplasty

Study on Perioperative Blood Protection Scheme Based on Total Hip Arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034377
Enrollment
Unknown
Registered
2020-07-04
Start date
2016-09-01
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Surgery

Interventions

one:TXA
two:temperature and TXA

Sponsors

Guangxi Zhuang Autonomous Region People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with first unilateral total hip arthroplasty

Exclusion criteria

Exclusion criteria: One-stage bilateral hip replacement, revision surgery, coagulopathy, blood diseases, malignant tumors, severe cardiopulmonary disorders, severe liver and kidney dysfunction, previous history of thromboembolism, hemoglobin below 90 g / L before surgery, seven days before surgery Use of anticoagulant drugs.

Design outcomes

Primary

MeasureTime frame
Bleeding volume;—

Countries

China

Contacts

Public ContactDong Yin

Guangxi Zhuang Autonomous Region People's Hospital

qyyyindong@126.com+86 13737097052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026